SCHEMBL2948491

SCHEMBL2948491

CC(C)CC(O)CCCCCO

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.39
CYP3A4 P08684 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PSMD14 O00487 2/20 0.36
PLA2G1B P04054 2/20 0.36
MMP2 P08253 2/20 0.36
ATG4B Q9Y4P1 2/20 0.36
HSP90AA1 P07900 1/20 0.36
RAD52 P43351 1/20 0.36
LMNA P02545 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TSHR P16473 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
TRPA1 O75762 1/20 0.36
PTPN1 P18031 1/20 0.34
GPR84 Q9NQS5 4/20 0.33
FFAR4 Q5NUL3 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5760929 1.00 USP2 (0.39) USP2CYP3A4SMN1; SMN2PSMD14PLA2G1B
SCHEMBL27076632 0.98 SMN1; SMN2 (0.36) USP2CYP3A4SMN1; SMN2PSMD14PLA2G1B
SCHEMBL5907087 0.90 USP2 (0.33) USP2CYP3A4SMN1; SMN2PSMD14PLA2G1B
SCHEMBL9832664 0.90 USP2 (0.33) USP2CYP3A4SMN1; SMN2PSMD14PLA2G1B
1,6-Hexanediol SCHEMBL8319566 0.87 TSHR (0.41) SMN1; SMN2LMNAALDH1A1HSD17B10MEN1
SCHEMBL16074691 0.86 PSMD14 (0.40) USP2CYP3A4SMN1; SMN2PSMD14PLA2G1B
SCHEMBL16074954 0.86 PSMD14 (0.40) USP2CYP3A4SMN1; SMN2PSMD14PLA2G1B
SCHEMBL16074953 0.86 PSMD14 (0.40) USP2CYP3A4SMN1; SMN2PSMD14PLA2G1B
SCHEMBL16077459 0.86 PSMD14 (0.40) USP2CYP3A4SMN1; SMN2PSMD14PLA2G1B
SCHEMBL16074901 0.86 PSMD14 (0.40) USP2CYP3A4SMN1; SMN2PSMD14PLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3218339-B1 PROCESS FOR THE PREPARATION OF HIGHER ALCOHOLS FROM ETHANOL AND N-HEXANOL BY GUERBET CONDENSATION ABENGOA BIOENERGIA NUEVAS TECNOLOGIAS SA (ES) 2022-01-05 EP disclosed
EP-2679303-B1 Catalyst and its preparation process for obtaining higher alcohols ABENGOA BIOENERGIA NUEVAS TECNOLOGIAS SA (ES) 2020-11-11 EP disclosed
US-10301241-B2 Process for the preparation of higher alcohols from lower alcohols by Guerbet condensation ABENGOA BIOENERGIA NUEVAS TECNOLOGIAS, S.A. (ES) 2019-05-28 US disclosed
EP-3087048-B1 PROCESS FOR THE PREPARATION OF HIGHER ALCOHOLS FROM LOWER ALCOHOLS BY GUERBET CONDENSATION ABENGOA BIOENERGIA NUEVAS TECNOLOGIAS SA (ES) 2019-03-20 EP disclosed
US-10118880-B2 Process for the preparation of higher alcohols from ethanol and N-hexanol by guerbet condensation ABENGOA BIOENERGIA NUEVAS TECNOLOGIES, S.A. (ES) 2018-11-06 US disclosed
US-20170327445-A1 PROCESS FOR THE PREPARATION OF HIGHER ALCOHOLS FROM ETHANOL AND N-HEXANOL BY GUERBET CONDENSATION CATALYXX INC. 2017-11-16 US disclosed
US-20160326075-A1 PROCESS FOR THE PREPARATION OF HIGHER ALCOHOLS FROM LOWER ALCOHOLS BY GUERBET CONDENSATION CATALYXX INC. 2016-11-10 US disclosed
US-9475741-B2 Method for obtaining higher alcohols ABENGOA BIOENERGÍA NUEVAS TECHNOLOGÍAS, S. A. (ES) 2016-10-25 US disclosed
US-9266096-B2 Catalyst for obtaining higher alcohols ABENGOA BIOENERGÍA NUEVAS TECNOLOGÍAS, S.A. (ES) 2016-02-23 US disclosed
EP-2889283-A1 Process for the preparation of n-butanol from ethanol and acetaldehyde Abengoa Bioenergía Nuevas Tecnologías, S. A. (ES) 2015-07-01 EP disclosed
EP-2889281-A1 Process for the preparation of n-butanol from ethanol and acetaldehyde Abengoa Bioenergía Nuevas Tecnologías, S. A. (ES) 2015-07-01 EP disclosed
EP-2889282-A1 Process for the preparation of n-butanol from ethanol and acetaldehyde Abengoa Bioenergía Nuevas Tecnologías, S. A. (ES) 2015-07-01 EP disclosed
US-20150166443-A1 METHOD FOR OBTAINING HIGHER ALCOHOLS CATALYXX INC. 2015-06-18 US disclosed
US-20150148569-A1 METHOD FOR OBTAINING HIGH ALCOHOLS CATALYXX INC. 2015-05-28 US disclosed
EP-2767336-A1 METHOD FOR OBTAINING HIGHER ALCOHOLS Abengoa Bioenergía Nuevas Tecnologías, S. A. (ES) 2014-08-20 EP disclosed
US-7763597-B2 Salts ASTRAZENECA AB (SE) 2010-07-27 US disclosed
US-20080269176-A1 New Salts ASTRAZENECA AB (SE) 2008-10-30 US disclosed
US-5789629-A METHYL BENZOATE, PROPIOPHENONE, 1,3-BUTANEDIOL, ANISOLE AND PHENOL EXTRACTANT BERG LLOYD (US) 1998-08-04 US disclosed
US-5763694-A DISTILLING MIXTURES OF COMPOUNDS HAVING CLOSE BOILING POINTS BY ADDING VOLATILITY-PROMOTING ORGANIC COMPOUND TO MIXTURE BERG LLOYD (US) 1998-06-09 US disclosed
US-5763695-A Separation of 3-methyl-1-butanol from 1-pentanol by extractive distillation BERG LLOYD (US) 1998-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269176-A1 New Salts PRSS1, PRSS2, CTRL USP2 2083/4885CYP3A4 195/4885SMN1; SMN2 3403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.